Off-label Drugs and Raynaud’s

A recent editorial in the Wall Street Journal by Dr. Joseph V. Gulfo, author of Innovation Breakdown:  How the FDA and Wall Street Cripple Medical Advances, reviews recent developments in the approval practices associated with off-label drugs. For those not familiar with the term, an off-label drug is one that is approved by the FDA